Duan and colleagues reported a significant correlation between tumor histology and median OS after TACE for patients with positive estrogen receptor (ER+) status (30 months) versus those with negative ER (ER–) status (18 months) [24]. The gene discussed is ESR1; the disease is neoplasm.